Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial
Article
Deb, S., Aimola, L., Leeson, V., Bodani, M., Li, L., Weaver, T., Sharp, D., Bassett, P. and Crawford, M. 2020. Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial. BMJ Open. 10 (9), pp. 1-12. https://doi.org/10.1136/bmjopen-2019-036300
Type | Article |
---|---|
Title | Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial |
Authors | Deb, S., Aimola, L., Leeson, V., Bodani, M., Li, L., Weaver, T., Sharp, D., Bassett, P. and Crawford, M. |
Abstract | Objectives: To conduct a feasibility randomised controlled trial of risperidone for the treatment of aggression in adults with traumatic brain injury (TBI). |
Keywords | psychiatry; adult psychiatry; impulse control disorders |
Publisher | BMJ Publishing Group |
Journal | BMJ Open |
ISSN | |
Electronic | 2044-6055 |
Publication dates | |
Online | 10 Sep 2020 |
10 Sep 2020 | |
Publication process dates | |
Deposited | 15 Sep 2020 |
Submitted | 10 Dec 2019 |
Accepted | 17 Jun 2020 |
Output status | Published |
Publisher's version | License |
Copyright Statement | © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. |
Digital Object Identifier (DOI) | https://doi.org/10.1136/bmjopen-2019-036300 |
Web of Science identifier | WOS:000572097100003 |
Language | English |
https://repository.mdx.ac.uk/item/8911x
Download files
48
total views20
total downloads1
views this month2
downloads this month